Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England

Journal of Oral Pathology and Medicine

Volumn 40, Issue 9, 2011, Pages 677-683

  Warnakulasuriya, S ^a   Kovacevic, T ^b   Madden, P ^c   Coupland, V H ^c   Sperandio, M ^d   Odell, E ^d   Moller H ^c  

^a King's and St Thomas' School of Medicine and Dentistry   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Dysplasia; Leukoplakia; Lichen planus; Oral cancer; Oral potentially malignant disorders; Transformation

Indexed keywords

ADULT; AGED; ARTICLE; DATA BASE; DYSPLASIA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LICHEN PLANUS; LICHENOID; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MOUTH CARCINOMA; ORAL BIOPSY; ORAL POTENTIALLY MALIGNANT DISORDER; PRECANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UNITED KINGDOM;

AGE FACTORS; AGED; BIOPSY; CANDIDIASIS, ORAL; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; COHORT STUDIES; EPITHELIUM; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; HYPERPLASIA; LEUKOPLAKIA, ORAL; LICHEN PLANUS, ORAL; LICHENOID ERUPTIONS; LONDON; LUPUS ERYTHEMATOSUS, DISCOID; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; REGISTRIES; RETROSPECTIVE STUDIES; SEX FACTORS; TONGUE NEOPLASMS;

EID: 80053599979     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01054.x     Document Type: Article

References (55)

1. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 2008; 37: 1-10.
2. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007; 36: 575-80.
3. van der Waal I, Schepman KP, van der Meij EH, Smeele LE. Oral leukoplakia: a clinicopathological review. Oral Oncol 1997; 33: 291-301.
4. Petti S. Pooled estimate of world leukoplakia prevalence: a systematic reviw. Oral Oncol 2003; 39: 770-80.
5. World Health Organization. Collaborating Centre for Oral Precancerous lesions. Definition of leukoplakia and related lesions; an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978; 46: 518-39.
6. Eveson JW. Oral premalignancy. Cancer Surv 1983; 2: 403-20.
7. Johnson NW, Ranasinghe AW, Warnakulasuriya KA. Potentially malignant lesions and conditions of the mouth and oropharynx: natural history-cellular and molecular markers of risk. Eur J Cancer Prev 1993; 2(Suppl 2): 31-51.
8. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa: present concept of management. Oral Oncol 2010; 46: 423-5.
9. Warnakulasuriya S, Cain N. Screening for oral cancer; contributing to the debate. J Invest Clin Dentistry 2011; 2: 2-9.
10. Arduino PG, Surace A, Carbone M, et al. Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up. J Oral Pathol Med 2009; 38: 540-4.
11. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol 2006; 42: 461-74.
12. Lee JJ, Hong WK, Hittelman WN, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 2000; 6: 1702-10.
13. Cowan C, Gregg T, Napier S, McKenna S, Kee F. Potentially malignant oral lesions in Northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis 2001; 7: 18-24.
14. Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 1998; 34: 270-5.
15. Bouquot JE. Reviewing oral leukoplakia: clinical concepts for the 1990s. J Am Dent Assoc 1991; 122: 80-2.
16. Lind PO. Malignant transformation in oral leukoplakia. Scand J Dent Res 1987; 95: 449-55.
17. Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984; 53: 563-8.
18. Axell T, Holmstrup P, Kramer I, Pindborg J, Shear M. International Seminar on Oral Leukoplakia and Associated Lesions Related to Tobacco Habits. Commun Dent Oral Epidemiol 1984; 12: 146-54.
19. World Health Organization Classification of Tumors. Pathology & Genetics. International Agency for Research on Cancer (IARC). In: Barnes L, Eveson JW, Reichart P, Sidransky D eds Head and Neck Tumours. Lyon: IARC Press, 2005; 177-80.
20. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 2008; 37: 127-33.
21. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003; 14: 47-62.
22. Saito T, Suguira C, Hirai A, et al. Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg 2001; 30: 49-53.
23. Scheifele C, Reichart PA. Is there a natural limit of the transformation rate of oral leukoplakia? Oral Oncol 2003; 39: 470-5.
24. Shiu MN, Chen TH. Intervention efficacy and malignant transformation to oral cancer among patients with leukoplakia (Review). Oncol Rep 2003; 10: 1683-92.
25. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol 1995; 79: 321-9.
26. Warnakulasuriya S. Histological grading of oral epithelial dysplasia: revisited. J Pathol 2001; 194: 294-7.
27. Speight P. Update on oral epithelial dysplasia and progression to cancer. Head and Neck Pathol 2007; 1: 61-6.
28. Bouquot J, Speight P, Farthing P. Epithelial dysplasia of the oral mucosa - diagnostic problems and prognostic features. Curr Diagn Pathol 2006; 12: 11-22.
29. Kramer IRH, Lucas RB, el-Labban N, Lister L. The use of discriminant analysis for examining the histological feathers of oral keratoses and lichen planus. Br J Cancer 1970; 24: 673-83.
30. Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 2006; 42: 987-93.
31. Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow up of oral dysplasia-a systematic review and meta-analysis. Head Neck 2009; 31: 1600-9.
32. Kramer IRH, El-Labban N, Lee KW. The clinical features and risk of malignant transformation in sublingual keratosis. Br Dent J 1978; 144: 171-80.
33. Waldron C, Shafer W. Leukoplakia revisited. Cancer 1975; 36: 1386-1392.
34. Carbone M, Arduino PG, Carrozzo M, et al. Course of oral lichen planus: a retrospective study of 808 northern Italian patients. Oral Dis 2009; 15: 235-43.
35. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 2002; 46: 207-14.
36. van der Meij EH, Mast H, van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol 2007; 43: 742-8.
37. Rodstrom PO, Jontell M, Mattsson U, Holmberg E. Cancer and oral lichen planus in a Swedish population. Oral Oncol 2004; 40: 131-8.
38. Lo Muzio L, Mignogna MD, Favia G, Procaccini M, Testa NF, Bucci E. The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature. Oral Oncol 1998; 34: 239-46.
39. Markopoulos AK, Antoniades D, Papanayotou P, Trigonidis G. Malignant potential of oral lichen planus; a follow-up study of 326 patients. Oral Oncol 1997; 33: 263-9.
40. Barnard NA, Scully C, Eveson JW, Cunningham S, Porter SR. Oral cancer development in patients with oral lichen planus. J Oral Pathol Med 1993; 22: 421-4.
41. Voute AB, de Jong WF, Schulten EA, Snow GB, van der Waal I. Possible premalignant character of oral lichen planus. The Amsterdam experience. J Oral Pathol Med 1992; 21: 326-9.
42. Holmstrup P, Thorn JJ, Rindum J, Pindborg JJ. Malignant development of lichen planus-affected oral mucosa. J Oral Pathol 1988; 17: 219-25.
43. Silverman S Jr, Gorsky M, Lozada-Nur F. A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association. Oral Surg Oral Med Oral Pathol 1985; 60: 30-4.
44. Gonzalez-Moles MA, Scully C, Gil-Montoya JA. Oral lichen planus: controversies surrounding malignant transformation. Oral Dis 2008; 14: 229-43.
45. Silverman S Jr. Oral lichen planus: a potentially premalignant lesion. J Oral Maxillofac Surg 2000; 58: 1286-8.
46. Chiesa F, Boracchi P, Tradati N, et al. Risk of preneoplastic and neoplastic events in operated oral leukoplakias. Eur J Cancer B Oral Oncol 1993; 29B: 23-8.
47. Einhorn J, Wersal J. Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa. Cancer 1967; 20: 2189-93.
48. Napier SS, Cowan CG, Gregg TA, Stevenson M, Lamey PJ, Toner PG. Potentially malignant oral lesions in Northern Ireland: size (extent) matters. Oral Dis 2003; 9: 129-37.
49. Vedtofte P, Holmstrup P, Hjorting-Hansen E, Pindborg JJ. Surgical treatment of premalignant lesions of the oral mucosa. Int J Oral Maxillofac Surg 1987; 16: 656-64.
50. Warnakulasuriya S. Squamous cell carcinoma and precursor lesions:prevention. Periodontology 2011; 57: 38-50.
51. Patridge M. A case control study confirms that microsateelite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cacnerization. Cancer Res 2000; 60: 3893-8.
52. Rosin MP, Cheng X, Poh C, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000; 6: 357-62.
53. Brennan M, Migliorati CA, Lockhart PB, et al. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103(Suppl 1): S19-S31.
54. Pitiyage G, Tilakaratne WM, Tavassoli M, Warnakulasuriya S. Molecular markers in oral epithelial dysplasia: review. J Oral Pathol Med 2009; 38: 737-52.
55. Torres-Rendon A, Stewart R, Craig GT, Wells M, Speight PM. DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression. Oral Oncol 2009; 45: 468-73.